The Antitrust Implications of Collaborative Standard Setting by Insurers Regarding the Use of Genetic Information in Life Insurance Underwriting
نویسنده
چکیده
منابع مشابه
Genetic testing for breast and ovarian cancer: implications for life insurance.
As the science of genetic testing progresses, the debate surrounding the uses of genetic information intensifies. In February, President Clinton signed an executive order prohibiting federal agencies from using such information to make hiring, promotion, or placement decisions. Concerns about privacy and discrimination have led many states to propose or enact statutes that prohibit health insur...
متن کاملProcess of Risk Analysis for Iranian Insurance Companies
The main challenge for any insurer/reinsurer has proved to be underwriting major refinery/Petrochemical risk. Insurers have already considered process risk management measures while accepting and evaluating the risks all over the world. Erstwhile petrochemical tariff was adopting experiencing methodology as basis for premium calculation in Iran. In the present de-tariff scenario decisions will ...
متن کاملAutomated Life Underwriting
Many life insurance companies are turning to technology to speed and remove cost from the underwriting process. Automated underwriting systems have been developed to reduce the manpower, time and/or data necessary to underwrite a life insurance application, while maintaining the quality of underwriting decisions. Although these systems have been in existence for some time, not much is known abo...
متن کاملShould Australia Ban the Use of Genetic Test Results in Life Insurance?
Under current Australian regulation, life insurance companies can require applicants to disclose all genetic test results, including results from research or direct-to-consumer tests. Life insurers can then use this genetic information in underwriting and policy decisions for mutually rated products, including life, permanent disability, and total income protection insurance. Over the past deca...
متن کاملUsing drugs to discriminate--adverse selection in the insurance marketplace.
399 health insurance but more acceptable to discriminate for products such as life, disability, and longterm care insurance. In defending the right to such discriminatory underwriting, insurers have claimed that if applicants have relevant information that isn’t available to insurers, such as robust genetic risk information, low-risk consumers will drop out of the mix and higher-risk consumers ...
متن کامل